Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Christoph

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Schizophrenia Research|November 7, 2006
White matter abnormalities and brain activation in schizophrenia: a combined DTI and fMRI studyRalf G M Schlösser, Igor Nenadic, Gerd Wagner, et al.
Journal of Cancer Research and Clinical Oncology|September 24, 2018
Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancerJan A Stratmann, Sebastian Michels, Sofia Hornetz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexedDaniel C Christoph, Andreas-Claudius Hoffmann, Thomas C Gauler, et al.
International Journal of Molecular Sciences|August 12, 2023
Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning ModelSabrina Borchert, Alexander Mathilakathu, Alina Nath, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2012
Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexedDaniel C Christoph, Bernadette Reyna Asuncion, Biftu Hassan, et al.
International Journal of Cancer|October 18, 2020
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trialMichael Staehler, Michael Stöckle, Daniel C Christoph, et al.
Translational Lung Cancer Research|March 4, 2022
A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancerZhenyang Zhang, Shuhan Xie, Weijing Cai, et al.
Translational Lung Cancer Research|August 25, 2021
Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment: a retrospective studyAlexander Mathilakathu, Sabrina Borchert, Michael Wessolly, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2011
Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophreniaC Christoph Schultz, Igor Nenadic, Kathrin Koch, et al.
Therapeutic Advances in Medical Oncology|February 22, 2021
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access programNikolaj Frost, Petros Christopoulos, Diego Kauffmann-Guerrero, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Schizophrenia Research|November 7, 2006
White matter abnormalities and brain activation in schizophrenia: a combined DTI and fMRI studyRalf G M Schlösser, Igor Nenadic, Gerd Wagner, et al.
Journal of Cancer Research and Clinical Oncology|September 24, 2018
Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancerJan A Stratmann, Sebastian Michels, Sofia Hornetz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexedDaniel C Christoph, Andreas-Claudius Hoffmann, Thomas C Gauler, et al.
International Journal of Molecular Sciences|August 12, 2023
Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning ModelSabrina Borchert, Alexander Mathilakathu, Alina Nath, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2012
Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexedDaniel C Christoph, Bernadette Reyna Asuncion, Biftu Hassan, et al.
International Journal of Cancer|October 18, 2020
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trialMichael Staehler, Michael Stöckle, Daniel C Christoph, et al.
Translational Lung Cancer Research|March 4, 2022
A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancerZhenyang Zhang, Shuhan Xie, Weijing Cai, et al.
Translational Lung Cancer Research|August 25, 2021
Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment: a retrospective studyAlexander Mathilakathu, Sabrina Borchert, Michael Wessolly, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2011
Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophreniaC Christoph Schultz, Igor Nenadic, Kathrin Koch, et al.
Therapeutic Advances in Medical Oncology|February 22, 2021
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access programNikolaj Frost, Petros Christopoulos, Diego Kauffmann-Guerrero, et al.
Pageof 11